RI

RTW Investments Portfolio holdings

AUM $7.02B
This Quarter Return
+22.03%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$270M
AUM Growth
Cap. Flow
+$270M
Cap. Flow %
100%
Top 10 Hldgs %
87.61%
Holding
21
New
21
Increased
Reduced
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TARO
1
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$39.7M 14.69% +267,883 New +$39.7M
ALNY icon
2
Alnylam Pharmaceuticals
ALNY
$58.5B
$33M 12.22% +340,395 New +$33M
DYAX
3
DELISTED
DYAX CORPORATION
DYAX
$30M 11.09% +2,131,808 New +$30M
BCRX icon
4
BioCryst Pharmaceuticals
BCRX
$1.74B
$27.5M 10.17% +2,261,361 New +$27.5M
ACHN
5
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$19.9M 7.35% +1,622,633 New +$19.9M
LJPC
6
DELISTED
La Jolla Pharmaceutical Company
LJPC
$19.6M 7.26% +1,064,247 New +$19.6M
ARWR icon
7
Arrowhead Research
ARWR
$3.05B
$19.3M 7.13% +2,610,000 New +$19.3M
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$18.4M 6.8% +1,115,981 New +$18.4M
ZSPH
9
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$15.6M 5.76% +374,821 New +$15.6M
RLYP
10
DELISTED
RELYPSA INC COM
RLYP
$13.9M 5.13% +450,239 New +$13.9M
XNPT
11
DELISTED
XENOPORT, INC.
XNPT
$7.39M 2.73% +842,568 New +$7.39M
VNDA icon
12
Vanda Pharmaceuticals
VNDA
$279M
$7.16M 2.65% +500,000 New +$7.16M
GYRE icon
13
Gyre Therapeutics
GYRE
$703M
$7.01M 2.59% +2,665,643 New +$7.01M
ADVM icon
14
Adverum Biotechnologies
ADVM
$64.6M
$2.7M 1% +50,000 New +$2.7M
RPRX
15
DELISTED
Repros Therapeutics Inc.
RPRX
$2.29M 0.85% +229,364 New +$2.29M
ASMB icon
16
Assembly Biosciences
ASMB
$190M
$1.6M 0.59% +204,000 New +$1.6M
PLX icon
17
Protalix BioTherapeutics
PLX
$124M
$1.55M 0.57% +843,851 New +$1.55M
LPCN icon
18
Lipocine
LPCN
$15.8M
$1.1M 0.41% +209,333 New +$1.1M
NVRO
19
DELISTED
NEVRO CORP.
NVRO
$594K 0.22% +15,356 New +$594K
APEN
20
DELISTED
Apollo Endosurgery, Inc.
APEN
$169K 0.06% +60,000 New +$169K